The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Boehringer Ingelheim is a global group of companies who seek to improve the health and wellbeing of people and animals through being a part of an independent, innovative, research and development driven company.
This programme consists of two elements, each with a different focus:
1. Regulation of secretion and/or function of pancreatic hormones. In particular, proposals dealing with the following are especially but not exclusively welcome: investigation of the role, function and mechanism of non-beta cells; crosstalk between various hormones and/or cell types of the endocrine pancreas. Only basic research projects will be considered for this Programme
2. Mechanisms relating renal dysfunction to cardiovascular disease in type 2 diabetes. In particular, proposals dealing with the following are especially, but not exclusively, welcome: projects investigating novel biomarkers or the translation of experimental hypotheses and clinical results. Only clinical / translational research projects will be considered for this Programme.
Deadline for submission of applications: 1 April 2014
Declaration of interest: IISPV's deadline: February 28th, 2014 (europa@iispv.cat)
Full proposal: IISPV's deadline: March 25th, 2014
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat